|
1
|
Jeong EM and Dudley SC Jr: New diagnostic
and therapeutic possibilities for diastolic heart failure. R I Med
J. 97:35–37. 2014.
|
|
2
|
Hunt SA, Abraham WT, Chin MH, Feldman AM,
Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K,
et al: ACC/AHA 2005 Guideline Update for the Diagnosis and
Management of Chronic Heart Failure in the Adult: a report of the
American College of Cardiology/American Heart Association Task
Force on Practice Guidelines (Writing Committee to Update the 2001
Guidelines for the Evaluation and Management of Heart Failure):
developed in collaboration with the American College of Chest
Physicians and the International Society for Heart and Lung
Transplantation: endorsed by the Heart Rhythm Society. Circulation.
112:e154–e235. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ahmed A, Young JB, Love TE, Levesque R and
Pitt B: A propensity-matched study of the effects of chronic
diuretic therapy on mortality and hospitalization in older adults
with heart failure. Int J Cardiol. 125:246–253. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Funder JW: Reconsidering the roles of the
mineralocorticoid receptor. Hypertension. 53:286–290. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McManus DD, Shah SJ, Fabi MR, Rosen A,
Whooley MA and Schiller NB: Prognostic value of left ventricular
end-systolic volume index as a predictor of heart failure
hospitalization in stable coronary artery disease: data from the
Heart and Soul Study. J Am Soc Echocardiogr. 22:190–197. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zannad F, McMurray JJ, Krum H, van
Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ and Pitt B:
EMPHASIS-HF Study Group: Eplerenone in patients with systolic heart
failure and mild symptoms. N Engl J Med. 364:11–21. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ahmed A, Zannad F, Love TE, Tallaj J,
Gheorghiade M, Ekundayo OJ and Pitt B: A propensity-matched study
of the association of low serum potassium levels and mortality in
chronic heart failure. Eur Heart J. 28:1334–1343. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Veilleux RP, Wight JN, Cannon A, Whalen M
and Bachman D: Home diuretic protocol for heart failure: partnering
with home health to improve outcomes and reduce readmissions. Perm
J. 18:44–48. 2009.
|
|
9
|
Pitt B, Remme W, Zannad F, Neaton J,
Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J and Gatlin M:
Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy
and Survival Study Investigators: Eplerenone, a selective
aldosterone blocker, in patients with left ventricular dysfunction
after myocardial infarction. N Engl J Med. 348:1309–1321. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grewal J, McKelvie R, Lonn E, Tait P,
Carlsson J, Gianni M, Jarnert C and Persson H: BNP and NT-proBNP
predict echocardiographic severity of diastolic dysfunction. Eur J
Heart Fail. 10:252–259. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Udelson JE, Feldman AM, Greenberg B, Pitt
B, Mukherjee R, Solomon HA and Konstam MA: Randomized,
double-blind, multicenter, placebo-controlled study evaluating the
effect of aldosterone antagonism with eplerenone on ventricular
remodeling in patients with mild-to-moderate heart failure and left
ventricular systolic dysfunction. Circ Heart Fail. 3:347–353. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Doehner W, Bunck AC, Rauchhaus M, von
Haehling S, Brunkhorst FM, Cicoira M, Tschope C, Ponikowski P,
Claus RA and Anker SD: Secretory sphingomyelinase is upregulated in
chronic heart failure: a second messenger system of immune
activation relates to body composition, muscular functional
capacity, and peripheral blood flow. Eur Heart J. 28:821–828. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yasuno S, Usami S, Kuwahara K, Nakanishi
M, Arai Y, Kinoshita H, Nakagawa Y, Fujiwara M, Murakami M and
Ueshima K: Endogenous cardiac natriuretic peptides protect the
heart in amouse model of dilated eardiomyopothy and sudden death.
Am J Physiol Heart Cite PhysioI. 296:H1804–H1810. 2009. View Article : Google Scholar
|
|
14
|
Verma A and Solomon SD: Diastolic
dysfunction as a link between hypertension and heart failure. Med
Clin North Am. 93:647–664. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Freel EM, Tsorlalis IK, Lewsey JD, Latini
R, Maggioni AP, Solomon S, Pitt B, Connell JM and McMurray JJ:
Aldosterone status associated with insulin resistance in patients
with heart failure - datafrom the ALOFT study. Heart. 95:1920–1924.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wikstrom G, Blomström-Lundqvist C, Andren
B, Lönnerholm S, Blomström P, Freemantle N, Remp T, Cleland JG, et
al: The effects of aetiology on outcome in patients treated with
cardiac resynchronization therapy in the CARE-HF trial. Eur Heart
J. 30:782–788. 2009. View Article : Google Scholar : PubMed/NCBI
|
